Arlin ZA - Search Results

1

Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.

Mittelman A, Savona S, Gafney E, Penichet KO, Lin BY, Levitt D, Ahmed T, Arlin ZA, Baskind P, Needleman D, et al. Mittelman A, et al. Among authors: arlin za. J Biol Response Mod. 1989 Oct;8(5):468-78. J Biol Response Mod. 1989. PMID: 2795092

2

Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells.

Hoffman M, Mittelman A, Dworkin B, Rosenthal W, Beneck D, Gafney E, Arlin Z, Levitt D, Podack E. Hoffman M, et al. J Cancer Res Clin Oncol. 1989;115(2):175-8. doi: 10.1007/BF00397920. J Cancer Res Clin Oncol. 1989. PMID: 2785519

3

Phase I trial of ImuVert (natural membrane vesicles associated with ribosomes) in patients with advanced cancer.

Mittelman A, Urban R, Wong G, Ahmed T, Arlin Z. Mittelman A, et al. Cancer Immunol Immunother. 1992;35(5):331-4. doi: 10.1007/BF01741146. Cancer Immunol Immunother. 1992. PMID: 1394337 Free PMC article. Clinical Trial.

4

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.

Feldman EJ, Alberts DS, Arlin Z, Ahmed T, Mittelman A, Baskind P, Peng YM, Baier M, Plezia P. Feldman EJ, et al. J Clin Oncol. 1993 Oct;11(10):2002-9. doi: 10.1200/JCO.1993.11.10.2002. J Clin Oncol. 1993. PMID: 8410125 Clinical Trial.

5

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

6

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

7

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.

Mittelman A, Savona S, Puccio C, Chun H, Ahmed T, Feldman E, Sullivan P, Arnold P, Arlin Z. Mittelman A, et al. Invest New Drugs. 1990;8 Suppl 1:S65-7. doi: 10.1007/BF00171986. Invest New Drugs. 1990. PMID: 1696246

8

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

Mittelman A, Chen ZJ, Kageshita T, Yang H, Yamada M, Baskind P, Goldberg N, Puccio C, Ahmed T, Arlin Z, et al. Mittelman A, et al. J Clin Invest. 1990 Dec;86(6):2136-44. doi: 10.1172/JCI114952. J Clin Invest. 1990. PMID: 2254463 Free PMC article. Clinical Trial.

9

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer.

Mittelman A, Ashikari R, Ahmed T, Savona S, Arnold P, Arlin Z. Mittelman A, et al. Cancer Chemother Pharmacol. 1988;22(1):63-4. doi: 10.1007/BF00254183. Cancer Chemother Pharmacol. 1988. PMID: 2456162

10

Cellular interactions in hemopoiesis.

Liu SJ, Ascensão JL, Podack E, Lin BY, Arlin Z, Lutton J, Gafney E, Baskind P, Mittelman A. Liu SJ, et al. Blood Cells. 1987;13(1-2):101-10. Blood Cells. 1987. PMID: 3117139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters